Programme
The DYVS take place on Wednesdays from 16:00-17:00 via Zoom.
We are always looking for enthusiastic speakers for upcoming seminars. Interested? See: KNVM Virology - Abstract submission
Upcoming seminars 2024:
Wednesday 21 February
Wednesday 17 April
Wednesday 19 June
Wednesday 18 September
Wednesday 20 November
Past seminars 2023
15 November 2023
Mass photometry as a tool to study viral proteins interactions
Tereza Kadavá, Utrecht University
Unraveling the role of heat shock protein 70 machines during CHIKV infections
Marleen van der Laan, University Medical Center Groningen
13 September 2023
Developing a nanobody toolkit to study the enterovirus 2C protein
Meryl Haas, Utrecht University
Bacteriophage therapy for burn wound infections
Michèle Molendijk, Erasmus MC
Wednesday 28 June
A profile of anti-viral antibody features associated with reduced disease progression in individuals with untreated HIV-1
Marloes Grobben, Amsterdam UMC
Antibody sequencing
Douwe Schulte, Utrecht University
12 April 2023
Mathematical modeling to understand the therapeutic response to oncolytic viruses
Darshak Bhatt, UMC Groningen
Transient Improvement of Fulminant Subacute Sclerosing Panencephalitis after Experimental Treatment with Remdesivir
Katharina Schmitz, Erasmus MC
15 February 2023
Dynamic immunodominance profiles of SARS-CoV-2 specific CD8+ T memory cells in convalescent donors
Jet van den Dijssel, Sanquin Research and Landsteiner Laboratory, AMC
Local and systemic transcriptomic profiling of monocytes shows host- pathogen interactions in children experiencing severe RSV infection
Klasina Chappin, UMC Utrecht
Past seminars 2022
30 November 2022
Unexpected use of human-type sialic acid receptors by avian influenza A viruses
Mengying Liu, Utrecht Univerisity
Understanding the complexity of DENV-induced inflammation and its impact on the course of disease
Bram ter Ellen, UMC Groningen
28 September 2022
Structural insights into host-pathogen interactions of Herpesvirus glycoprotein B and Myelin-associated Glycoprotein
Sabrina Krepel, Utrecht University
RNA recombination between self-amplifying mRNA vaccines and wild-type alphaviruses
Tessy Hick, Wageningen University & Research
22 June 2022
Intra-host evolution of human Norovirus during chronic infections and insights into the outcome of immunoglobulin treatment
Ray Izquierdo Lara, Erasmus MC
Persistent infection of seasonal and pandemic influenza viruses in a hiPSC-derived neural model
Feline Benavides, Erasmus MC
20 April 2022
Distinct spatial arrangements of ACE2 and TMPRSS2 expression in Syrian hamster lung lobes dictates SARS-CoV-2 infection patterns
Ilhan Tomris, Utrecht University
Characterization of the HIV-1 subtype C reservoir during ART in South-African men and women
Ninée Buchholtz, UMC Utrecht
16 February 2022
Non-human primate adenoviruses of the Human Adenovirus B species are potent and broadly-acting oncolytic vector candidates
Selas Bots, LUMC
SARS-CoV-2 Omicron-specific humoral and cellular immunity in COVID-19 vaccinees
Daryl Geers, Erasmus MC
Past seminars 2021
17 November 2021
Diversity and long-term dynamics of human blood anelloviruses
Joanna Kaczorowska, WUR
Two-component nanoparticle vaccine displaying glycosylated SARS-CoV-2 spike S1 domain produced in insect cells
Linda van Oosten, Amsterdam UMC
20 October 2021
mRNA vaccination boosts existing cellular responses and enhances protection against lethal H7N9 challenge in ferrets
Koen van de Ven, RIVM
Macrocyclic peptides targeting the hemagglutinin stem region potently inhibit H1 and H5 influenza A viruses
Mirte Pascha, Utrecht University
15 September 2021
Antiviral and immunoregulatory effects of LL-37 against dengue infection in macrophages
Jorge Andrés Castillo, UMC Groningen
Analysis of influenza virus specific B cells reveals a diverse set of antibodies towards different domains of the influenza virus hemagglutinin
Aafke Aartse, BPRC
16 June 2021
Identification of a novel inhibitor of Zika virus replication
Bodine Bezemer, Radboud UMC
SARS-CoV-2 does not trigger TLR4
Lieve van der Donk, Amsterdam UMC
19 May 2021
Varicella-zoster virus VLT and VLT-ORF63 proteins are dispensable for lytic infection in cell culture
Shirley Braspenning, Erasmus MC
SARS-CoV-2 Infection Depends on Heparan Sulfates and Is Blocked by Low Molecular Weight Heparins
Julia Eder, Amsterdam UMC